Valuation: Neuland Laboratories Limited

Market Cap 28TCr 293.21Cr 257.29Cr 243Cr 221.45Cr 414.54Cr 417.5Cr 2.91TCr 1.13TCr 14TCr 1.1TCr 1.08TCr 46TCr P/E 2027 *
58.8x
P/E 2028 * 45x
Enterprise Value 28TCr 295.88Cr 259.64Cr 245.22Cr 223.47Cr 418.32Cr 421.31Cr 2.93TCr 1.14TCr 14TCr 1.11TCr 1.09TCr 47TCr EV / Sales 2027 *
11.6x
EV / Sales 2028 * 9.64x
Free-Float
62.26%
Yield 2027 *
0.11%
Yield 2028 * 0.14%
1 day-0.02%
1 week-4.25%
Current month-4.49%
1 month-4.58%
3 months+22.11%
6 months+81.44%
Current year+44.20%
1 week 21,800
Extreme 21800
23,030.95
1 month 21,800
Extreme 21800
24,235.05
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 3,612.05
Extreme 3612.05
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 47 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-0.02%-4.25%+47.84%+475.56% 293.21Cr
+0.13%+2.65%+65.61%+114.28% 1,05500Cr
+0.20%+0.46%+52.60%+69.24% 65TCr
-0.29%+0.14%+20.96%+70.93% 47TCr
-0.85%+0.98%+41.29%+44.38% 35TCr
+0.71%+4.08%+22.24%+29.51% 27TCr
+1.23%+0.42%+14.57%+12.13% 26TCr
+2.11%+7.51%+52.89%+55.37% 22TCr
+0.83%+0.55%+35.99%+101.70% 19TCr
0.00%-10.14%-29.94%-60.30% 17TCr
Average +0.32%+0.24%+32.41%+91.28% 36.41TCr
Weighted average by Cap. +0.02%+1.31%+41.54%+68.16%

Financials

2027 *2028 *
Net sales 2.44TCr 25Cr 22Cr 21Cr 19Cr 36Cr 36Cr 252.84Cr 98Cr 1.25TCr 96Cr 94Cr 4.01TCr 2.93TCr 31Cr 27Cr 25Cr 23Cr 43Cr 43Cr 302.83Cr 117.29Cr 1.5TCr 114.65Cr 112.17Cr 4.81TCr
Net income 479.83Cr 5.01Cr 4.39Cr 4.15Cr 3.78Cr 7.08Cr 7.13Cr 50Cr 19Cr 245.14Cr 19Cr 18Cr 787.84Cr 626.47Cr 6.54Cr 5.74Cr 5.42Cr 4.94Cr 9.24Cr 9.31Cr 65Cr 25Cr 320.05Cr 25Cr 24Cr 1.03TCr
Net Debt 256.12Cr 2.67Cr 2.34Cr 2.21Cr 2.02Cr 3.78Cr 3.8Cr 27Cr 10Cr 130.85Cr 10Cr 9.82Cr 420.52Cr 98Cr 1.02Cr 89.67L 84.68L 77.17L 1.44Cr 1.45Cr 10Cr 3.93Cr 50Cr 3.84Cr 3.75Cr 160.8Cr
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
25/26/25 ₹21,903.95 -0.02% 4,310
24/26/24 ₹21,909.40 -2.60% 2,043
23/26/23 ₹22,493.30 -0.16% 1,008
22/26/22 ₹22,529.55 -0.31% 1,686
21/26/21 ₹22,600.70 -1.20% 1,640
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21,903.95INR
Average target price
24,334.75INR
Spread / Average Target
+11.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock